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Lymphocytic Choriomeningitis Virus:
An Unrecognized Teratogenic Pathogen
Lymphocytic choriomeningitis virus (LCMV),
the first member of the arenavirus family to be
isolated, is the causative agent of a zoonosis ac-
quired from chronically viremic mice or hamsters
(1). The clinical spectrum of acquired human
LCMV infection ranges from inapparent and
asymptomatic to, in rare instances, severely
symptomatic, systemic, and fatal central nervous
system (CNS) disease. Intrauterine LCMV infec-
tion has resulted in fetal or neonatal death, as well
as hydrocephalus and chorioretinitis in infants
(2-6). We have diagnosed congenital LCMV infec-
tion in three infants (7) and have collated pub-
lished and unpublished data on three additional
affected infants (8, G.R. Istre, pers. comm.). This
report briefly summarizes the salient features of
the infection in five of these six American infants
and outlines the similarities between these and
features observed earlier in Europe. We suggest
that LCMV is a more frequent cause of CNS dis-
ease in newborns than previously recognized.
Congenital LCMV infection was first recog-
nized in Great Britain in an infant who died at 12
days of age (3). Subsequently, fetal infection with
spontaneous abortion (2) and congenital infection
in liveborn infants with hydrocephalus and chori-
oretinitis were documented in Germany (4),
France (6), and Lithuania (5). We have recently
documented congenital LCMV infection in three
infants from Arizona (7) and have obtained infor-
mation regarding three additional neonates from
Arizona, Nebraska (8), and Texas (G.R. Istre, pers.
comm.). Detailed clinical and laboratory data are
available for five of the six infants. All displayed
nonobstructive hydrocephalus with periventricu-
lar calcifications, chorioretinitis, and psychomotor
retardation. One of the five infants had sensor-
ineural deafness. None of the infants had cardiac
abnormalities. Two infants have had follow-up
ophthalmologic and audiologic examinations
which have shown neither the progression of
chorioretinitis nor the development of new audi-
tory deficits. Toxoplasma gondii, cytomegalovirus,
Herpes simplex virus, rubella, enterovirus, and
Treponema pallidum infections were excluded by
culture or serology in all infants. The diagnosis of
congenital LCMV infection was confirmed in all
infants by immunofluorescence antibody (IFA)
and enzyme-linked immunosorbent assays
(ELISAs). In addition, serum, CSF, urine, and
throat wash specimens from two infants were
injected into Vero cell monolayers. Neither cytopa-
thic effect nor LCMV antigens were detected after
incubation. Because virus isolation was only at-
tempted after the disease was first diagnosed
when the children were 10 months of age, failure
to isolate LCMV was not unanticipated.
Laboratory diagnosis of LCMV infection is gen-
erally made by serologic techniques. IFA is a more
sensitive diagnostic method than either comple-
ment fixation or neutralizing antibody techniques
(9,10). The newer ELISAs are now being used to
evaluate congenitally infected infants. Testing the
child’s serum and CSF and a simultaneously ob-
tained serum specimen from the mother yields the
maximum information if done as soon after birth
as possible.
The mothers of four of the five infants in this
report had a history of febrile illness during preg-
nancy, in contrast to a minority of mothers of
affected infants previously reported. Typical
LCMV infection in adults is a biphasic disease
with fever, malaise, myalgias, anorexia, nausea,
vomiting, pharyngitis, cough, and adenopathy fol-
lowed by defervescence and a second phase of CNS
disease. However, CNS symptoms may appear
without any prodrome or may never develop. Men-
ingitis and meningoencephalitis are the most fre-
quent neurologic manifestations of disease,
although myelitis, Guillain-Barré syndrome, and
sensorineural deafness have been reported (11).
Between 1941 and 1958, 8% to 11% of viral CNS
syndromes in hospitalized patients in a Washing-
ton, D.C., medical center were etiologically associ-
ated with LCMV (12). Arthritis, parotitis, orchitis,
myocarditis, and rash have also been noted (13).
Clinical interest in LCMV, however, has not been
maintained, and the disease is rarely considered
despite improved serodiagnostic methods.
Although a history of contact with rodents and
their excreta is of diagnostic utility, it is not uni-
versally present. A maternal history of rodent
exposure was elicited for three of our five infants.
Wild mice (Mus musculus) and hamsters infected
in utero with LCMV during maternal viremia
develop both persistent viremia and viruria. The
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contact; by contact with infected rodent saliva,
nasal secretions, urine, feces, semen, and milk;
and by infectious aerosols (1). Human-to-human
transmission has not been documented. The dis-
tribution of LCMV is highly variable within mouse
populations. Seasonal, annual, and cyclical vari-
ations in rodent density and infection have been
postulated but remain inadequately studied (14).
LCMV spreads to humans in rural settings or
when human habitats are substandard. Infected
laboratory and pet rodents have also been associ-
ated with disease in humans (1). Serologic surveys
and clinical studies have documented both epi-
demic and endemic human infection in Europe
and the Americas. In Baltimore, 9.0% of house
mice and 4.7% of residents have had measurable
LCMV antibody (15,16).
We hypothesize that congenital LCMV infec-
tion is generally undiagnosed and may account for
unexplained hydrocephalus with microcephaly or
macrocephaly, deafness, blindness, and mental re-
tardation (three of the five infants in this report
were referred for infectious disease consultation
by pediatric geneticists, and two were referred by
pediatric neurologists). No accurate data are
available regarding the prevalence and persist-
ence of LCMV antibodies in unselected infants,
children, and adults in diverse geographic locales
or in children with unexplained visual and/or
auditory deficits, microcephaly, and retardation.
Increased recreational activities in rural environ-
ments, rehabilitation of and habitation in older
rodent-infected domiciles, and acquisition of un-
screened rodents for pets or laboratory use pose as
yet undefined risks for LCMV infection to the
fetus, child, and adult. The need for further re-
search to define the frequency of LCMV infection
in human and animal populations is clear. LCMV
infection can best be prevented by educating the
public and medical professionals on the hazards of
contact with infected rodents.
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